133 related articles for article (PubMed ID: 25663449)
41. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
42. Genetic variants associated with osteosarcoma risk: a systematic review and meta-analysis.
Hassanain O; Alaa M; Khalifa MK; Kamal N; Albagoury A; El Ghoneimy AM
Sci Rep; 2024 Feb; 14(1):3828. PubMed ID: 38360742
[TBL] [Abstract][Full Text] [Related]
43. Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma.
Yang W; He M; Zhao J; Wang Z
Med Oncol; 2014 Feb; 31(2):826. PubMed ID: 24381140
[TBL] [Abstract][Full Text] [Related]
44. Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk.
Zhang C; Wiemels JL; Hansen HM; Gonzalez-Maya J; Endicott AA; de Smith AJ; Smirnov IV; Witte JS; Morimoto LM; Metayer C; Walsh KM
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1151-1158. PubMed ID: 30038050
[No Abstract] [Full Text] [Related]
45. Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.
Lu H; Zhu L; Lian L; Chen M; Shi D; Wang K
Tumour Biol; 2015 Jul; 36(7):5241-7. PubMed ID: 25663494
[TBL] [Abstract][Full Text] [Related]
46. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".
Jian Y; Tian X; Li B; Zhou Z; Wu X
Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708
[TBL] [Abstract][Full Text] [Related]
47. Genetic Polymorphisms of Insulin-Like Growth Factor 1 Are Associated with Osteosarcoma Risk and Prognosis.
Mao J; Zhuang G; Chen Z
Med Sci Monit; 2017 Dec; 23():5892-5898. PubMed ID: 29232358
[TBL] [Abstract][Full Text] [Related]
48. Effect of TIMP2/TIMP3 genes on the risk of osteosarcoma in Zhejiang population.
Wu Z; Chen H; Pan L; Yu W; Lou C; Chen J; He D
Medicine (Baltimore); 2021 Mar; 100(11):e24818. PubMed ID: 33725949
[TBL] [Abstract][Full Text] [Related]
49. CNOT1 cooperates with LMNA to aggravate osteosarcoma tumorigenesis through the Hedgehog signaling pathway.
Cheng DD; Li J; Li SJ; Yang QC; Fan CY
Mol Oncol; 2017 Apr; 11(4):388-404. PubMed ID: 28188704
[TBL] [Abstract][Full Text] [Related]
50. Black carbon exposures, blood pressure, and interactions with single nucleotide polymorphisms in MicroRNA processing genes.
Wilker EH; Baccarelli A; Suh H; Vokonas P; Wright RO; Schwartz J
Environ Health Perspect; 2010 Jul; 118(7):943-8. PubMed ID: 20211803
[TBL] [Abstract][Full Text] [Related]
51. Ras-Association Domain Family 1 Isoform A (RASSF1A) Gene Polymorphism rs1989839 is Associated with Risk and Metastatic Potential of Osteosarcoma in Young Chinese Individuals: A Multi-Center, Case-Control Study.
Xu H; Zhan W; Chen Z
Med Sci Monit; 2016 Nov; 22():4529-4535. PubMed ID: 27880743
[TBL] [Abstract][Full Text] [Related]
52. Genetic variations in microRNA processing genes are associated with susceptibility in depression.
He Y; Zhou Y; Xi Q; Cui H; Luo T; Song H; Nie X; Wang L; Ying B
DNA Cell Biol; 2012 Sep; 31(9):1499-506. PubMed ID: 22694265
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA variants as genetic determinants of bone mass.
Dole NS; Delany AM
Bone; 2016 Mar; 84():57-68. PubMed ID: 26723575
[TBL] [Abstract][Full Text] [Related]
54. Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules.
Poos K; Smida J; Maugg D; Eckstein G; Baumhoer D; Nathrath M; Korsching E
PLoS One; 2015; 10(4):e0123082. PubMed ID: 25848766
[TBL] [Abstract][Full Text] [Related]
55. Translesion polymerase genes polymorphisms and haplotypes influence survival of osteosarcoma patients.
Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
OMICS; 2015 Mar; 19(3):180-5. PubMed ID: 25748439
[TBL] [Abstract][Full Text] [Related]
56. Lysyl oxidase polymorphisms and susceptibility to osteosarcoma.
Liu Y; Lv B; He Z; Zhou Y; Han C; Shi G; Gao R; Wang C; Yang L; Song H; Yuan W
PLoS One; 2012; 7(7):e41610. PubMed ID: 22911823
[TBL] [Abstract][Full Text] [Related]
57. MAPK7 variants related to prognosis and chemotherapy response in osteosarcoma.
Tesser-Gamba F; Paolillo AT; Del Giúdice Paniago M; Petrilli AS; Seixas Alves MT; Garcia Filho RJ; Toledo SRC
Ann Diagn Pathol; 2020 Jun; 46():151482. PubMed ID: 32145682
[TBL] [Abstract][Full Text] [Related]
58. Genetic determinants of childhood and adult height associated with osteosarcoma risk.
Zhang C; Morimoto LM; de Smith AJ; Hansen HM; Gonzalez-Maya J; Endicott AA; Smirnov IV; Metayer C; Wei Q; Eward WC; Wiemels JL; Walsh KM
Cancer; 2018 Sep; 124(18):3742-3752. PubMed ID: 30311632
[TBL] [Abstract][Full Text] [Related]
59. Review of microRNA in osteosarcoma and chondrosarcoma.
Chang L; Shrestha S; LaChaud G; Scott MA; James AW
Med Oncol; 2015 Jun; 32(6):613. PubMed ID: 25920607
[TBL] [Abstract][Full Text] [Related]
60. XPO5 genetic polymorphisms in cancer risk and prognosis.
Patrão AS; Dias F; Teixeira AL; Maurício J; Medeiros R
Pharmacogenomics; 2018 Jun; 19(9):799-808. PubMed ID: 29790454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
